Patents matching “treatment”

US 9617305

Treatments for gastrointestinal disorders

IRONWOOD PHARMACEUTICALS, INC. · Granted Apr 11, 2017 · Expires Apr 6, 2037

US 9616047

Inhibitors of beta-catenin in treatment of colorectal cancer

Regents of the University of Minnesota · Granted Apr 11, 2017 · Expires Apr 6, 2037

US 9611230

1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

PTC THERAPEUTICS, INC. · Granted Apr 4, 2017 · Expires Mar 30, 2037

US 9603796

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

The Regents of the University of California · Granted Mar 28, 2017 · Expires Mar 23, 2037

US 9603820

Ornithine aminotransferase inhibition with GABA analogues for treatment of hepatocellular carcinoma

Northwestern University · Granted Mar 28, 2017 · Expires Mar 23, 2037

US 9603806

Pharmaceutical compositions for the treatment of Helicobacter pylori

RedHill Biopharma Ltd. · Granted Mar 28, 2017 · Expires Mar 23, 2037

US 9597302

Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibrillation

Heart Rhythm Solutions, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

US 9597336

Therapy for treatment of chronic degenerative brain diseases and nervous system injury

The Regents of the University of California · Granted Mar 21, 2017 · Expires Mar 16, 2037

US 9593069

Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis

Northwestern University · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9593108

Compounds and methods for antiviral treatment

PTC THERAPEUTICS, INC. · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9586930

1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

Takeda Pharmaceutical Company Limited · Granted Mar 7, 2017 · Expires Mar 2, 2037

US 9585863

Treatment of cataplexy

Jazz Pharmaceuticals International III Limited · Granted Mar 7, 2017 · Expires Mar 2, 2037

US 9585935

Intranasal oxytocin treatment to improve schizophrenia

The Regents of the University of California · Granted Mar 7, 2017 · Expires Mar 2, 2037

US 9585878

Treatment of BDNF-related disorders using laquinimod

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 7, 2017 · Expires Mar 2, 2037

US 9580438

Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders

4SC DISCOVERY GMBH · Granted Feb 28, 2017 · Expires Feb 23, 2037

US 9579346

Treatment of macrophage-related disorders

The Regents of the University of California · Granted Feb 28, 2017 · Expires Feb 23, 2037

US 9574243

Compositions and methods for the treatment of influenza infection

Lakewood Amedex, Inc. · Granted Feb 21, 2017 · Expires Feb 16, 2037

US 9572828

Treatment for melanoma

The Board of Regents of the University of Texas System · Granted Feb 21, 2017 · Expires Feb 16, 2037

US 9573948

Triazolopyridine compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC · Granted Feb 21, 2017 · Expires Feb 16, 2037

US 9574211

Methods and compositions for prevention or treatment of a disease

Sangamo Biosciences, Inc. · Granted Feb 21, 2017 · Expires Feb 16, 2037

US 9568476

Diagnosis and treatment of breast cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 14, 2017 · Expires Feb 9, 2037

US 9566348

Methods and compositions for the treatment of cancer and infectious disease using alpha(2) macroglobulin-antigenic molecule complexes

University of Connecticut Health Center · Granted Feb 14, 2017 · Expires Feb 9, 2037

US 9562217

Modalities for the treatment of degenerative diseases of the retina

Astellas Institute for Regenerative Medicine · Granted Feb 7, 2017 · Expires Feb 2, 2037

US 9561256

LLP2A-bisphosphonate conjugates for osteoporosis treatment

The Regents of the University of California · Granted Feb 7, 2017 · Expires Feb 2, 2037